{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:44Z","timestamp":1786991324882,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,6]],"date-time":"2027-07-06T00:00:00Z","timestamp":1814832000000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01AI155393"],"award-info":[{"award-number":["P01AI155393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaip.2026.03.041","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:49:56Z","timestamp":1776354596000},"page":"1506-1514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Anna","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Agharahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphanie P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Weixiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-3701","authenticated-orcid":false,"given":"Christine M.","family":"Seroogy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.03.041_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib2","article-title":"Utility of serum cytokine testing to differentiate complicated common variable immunodeficiency in resource limited settings","volume":"4","author":"Jogdand","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.03.041_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.03.041_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451433","article-title":"Monogenic Common Variable Immunodeficiency (Mo-CVID) Score for optimizing the genetic diagnosis in pediatric CVID cohort","volume":"55","author":"Barbati","year":"2025","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2025.10.022","article-title":"Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling","volume":"157","author":"Schwitzkowski","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","article-title":"Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts","volume":"130","author":"Chapel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1497921","article-title":"Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation","volume":"15","author":"Cortesi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaip.2023.01.048","article-title":"The rapidly expanding genetic spectrum of common variable immunodeficiency-like disorders","volume":"11","author":"Ameratunga","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.jaip.2026.03.041_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10875-025-01896-w","article-title":"Genetics in a Danish common variable immunodeficiency cohort","volume":"45","author":"Drabe","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de Valles-Ibanez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clim.2015.05.020","article-title":"Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders","volume":"160","author":"van Schouwenburg","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib26","doi-asserted-by":"crossref","first-page":"1272912","DOI":"10.3389\/fgene.2023.1272912","article-title":"Genetics and clinical phenotypes in common variable immunodeficiency","volume":"14","author":"Cunningham-Rundles","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jaip.2026.03.041_bib27","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","article-title":"Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy","volume":"10","author":"Christiansen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2215\/CJN.0000000000000438","article-title":"Nonlupus full house nephropathy: a systematic review","volume":"19","author":"Uzzo","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaip.2026.03.041_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.03.041_bib12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.03.041_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2026.03.041_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108316","article-title":"Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity","volume":"210","author":"Jagle","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400348","article-title":"JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review","volume":"15","author":"Atschekzei","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib18","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.03.041_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.041_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.03.041_bib21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826003284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826003284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:54:19Z","timestamp":1783331659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826003284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2213219826003284"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.03.041","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}